The Recall Desk

FDA (Drugs) recall action 74126

Allergan Sales, LLC recalled 2 products on 2016-07-13

The FDA (Drugs) publishes a recall like this one as 2 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 2 pages.

Products
2
Announced
2016-07-13
Critical
0
Units
17,802

Why these products were recalled

Failed Content Uniformity Specifications.

The agency’s own wording, quoted from the enforcement report.

The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.

States named across these recalls

1–2 of 2

  • ModerateFDA (Drugs)··2016-07-13

    Allergan Recalls Tazorac Gel 0.05% Due to Content Uniformity Failures

    Allergan is recalling Tazorac (tazarotene) Gel 0.05% because the product failed content uniformity specifications. The recall covers 17,802 units distributed nationwide and in Puerto Rico.

    Product
    Tazorac (tazarotene) Gel 0.05%, Rx only, packaged in a) 30g (NDC 0023-8335-03) and b) 100g (NDC 0023-8335-10) tubes, Allergan Inc, Irvine, CA 92612
    Category
    Distribution
    1 state